Owen K
GlaxoWellcome Research and Development, Ware, Hertfordshire, UK.
J Antimicrob Chemother. 1998 Aug;42(2):261-4. doi: 10.1093/jac/42.2.261.
This study was performed in order to compare the phototoxic potential of grepafloxacin (a new fluoroquinolone for the treatment of respiratory tract infections) with that of a number of marketed fluoroquinolones. Groups of Balb/c mice received either control material or grepafloxacin, lomefloxacin, sparfloxacin, ofloxacin, ciprofloxacin or enoxacin at an oral dose of 200 mg/kg before being exposed to 20 J/cm2 longwave ultraviolet irradiation for 110-115 min. Lomefloxacin and sparfloxacin caused erythema and oedema which were often severe and lasted the full 7 days of the study. Enoxacin caused a long-lasting erythema, while the erythema seen following the administration of grepafloxacin, ciprofloxacin and ofloxacin was relatively mild and short-lived. The results of this study demonstrate the good safety profile of grepafloxacin in terms of phototoxicity.
本研究旨在比较格帕沙星(一种用于治疗呼吸道感染的新型氟喹诺酮类药物)与多种市售氟喹诺酮类药物的光毒性潜力。将Balb/c小鼠分组,在接受20 J/cm2长波紫外线照射110 - 115分钟之前,以200 mg/kg的口服剂量给予对照物质或格帕沙星、洛美沙星、司帕沙星、氧氟沙星、环丙沙星或依诺沙星。洛美沙星和司帕沙星引起红斑和水肿,症状通常严重,且在研究的整整7天内持续存在。依诺沙星引起持久的红斑,而给予格帕沙星、环丙沙星和氧氟沙星后出现的红斑相对较轻且持续时间较短。本研究结果表明,格帕沙星在光毒性方面具有良好的安全性。